Background: Diabetes Mellitus (DM) is one of the common metabolic disorders that have effects on lipid metabolism. Fish oil supplementation may improve lipid abnormalities in diabetic patient.Objective: To observe the effect of supplementation of omega-3 fatty acid on total cholesterol (TC) and triglyceride(TG) level in type 2 DM. Methods: A prospective interventional study was conducted from January 2017 to December 2017. A total numbers of 52 diagnosed type 2 diabetic patients of both sexes were selected with age 40 to 50 years. Among them, 27 type 2 diabetic patient with supplementation of omega 3 fatty acid (2g/ day) for 12 weeks was considered as study group. Another 25 type 2 diabetic patients without supplementation of omega 3 fatty acid was considered as control group. The study subjects were selected from Outpatient Department of Endocrinology, Dhaka Medical College Hospital, Dhaka and personal contact from Dhaka city.Serum TC and TG were estimated by enzymatic endpoint method in autoanalyzer.The study parameters were measured at base line and after 12 weeks of study period in both groups. For statistical analysis, Paired Student's't' test and Unpaired Student's 't' test were performed as applicable using SPSS for windows version 16.0. Results: In this study serumTC and TG levels were significantly lower (p<.001) in diabetic patients after supplementation with omega-3 fatty acid in comparison to that of their baseline value.Again, after 12 weeks, serum TC and TG levels were significantly lower (p<.001) in diabetic patients after supplementation with omega-3 fatty acid in comparison to control group. In control group, serum TC and TG levels were almost similar both at baseline and after 3 months of follow-up. Conclusion: After analyzing the results of the study, it can be concluded that omega-3 fatty acid may improve serum TC and TG levels in type 2 diabetic patient and may be helpful to minimize the complications of type-2 DM.
M is a group of metabolic disease characterized by hyperglycemia resulting from defect in insulin secretion Introduction D or insulin action or both. The chronic hyperglycemia of diabetes is associated with long term damage dysfunction and failure of various organs especially the eyes, kidneys, nerve, heart and blood vessel 1 .Diagnostic criteria of DM are fasting plasma glucose level ≥7.0mmol/l (126mg/ dl) or plasma glucose 2 hours after an oral glucose ≥11.1 mmol /L (200mg/dl) and HbA1c ≥ 6.5% 2 . The prevalence of T2DM is expected to rise from 285 million in 2010 to 438 million by the year of 2030 3 .Within 2030, the prevalence of DM will be 11.1 million in Bangladesh 4. Insulin is the potent anabolic hormone which is essential for appropriate tissue development, growth and maintenance of whole body glucose homeostasis. Insulin regulates glucose homeostasis by increasing the rate of glucose uptake into striated muscle and adipose tissue.In the skeletal muscle, insulin prompts glucose uptake by stimulating translocation of GLUT-4 to plasma membrane 5 . Insulin resistance occurs when the insulin sensitive tissue loses response to insulin. The basic effect of insulin resistance on glucose metabolism is to prevent the uptake and utilization of glucose by most cells of the body. As a result blood glucose concentration increases, cell utilization of glucose falls, utilization of fat increases and free fatty acid level increases in blood 6 .
Omega-3 Fatty acids are a group of polyunsaturated fatty acids consists of alphalinolenic acid (ALA), eicosapentaenoic acid (EPA) and docosahexanoic acid (DHA). They are found in seafood including fatty fish (e.g. salmon, tuna and trout) and shellfish (e.g. crab, mussels and oysters).The omega 3 fatty acid; increases insulin sensitivity, helps in blood clotting, promote fat digestion, improve fertility, acts as a mood elevator and helps in brain development 7 .
Consumption of fish oil can decreases free fatty acid level, improve insulin sensitivity as well as reduce the incidence of type 2 DM 8 . Poly unsaturated fatty acid act directly on insulin sensitive tissues, increases number of insulin receptors thus reducing insulin resistance 9 . Omega-3 fatty acid facilitates the action of insulin through various metabolic pathways and improve glycemic status in type-2 DM. It also facilitates the action of insulin through suppression of hepatic lipogenesis and reduces the release of TG from liver and oxidation of fatty acids in liver, thus reduces the complications in type-2 DM 10 .
Omega-3 fatty acid prevents this change by increasing peroxisome proliferator receptor gamma, increasing hepatic uptake and oxidation of free fatty acid in skeletal muscle 11 .Some author found significant reduction in serum TC and TG levels in diabetic patient those are supplemented with fish oil 12 .As lipid abnormalities are common in type 2 DM. Supplementation of fish oil may prevent lipid abnormalities and reduce complications in diabetic patients.
As thereis less published data available regarding this topic in our country. Therefore, this study has been designed about the supplementation of omega-3 fatty acid on lipid profile level in Bangladeshi type-2 DM patients. It is expected that findings of this study will be helpful for better management and its complication.
Methods
This prospective, interventional study was done from Department of Physiology, Dhaka Medical College, Dhaka from January 2017 to December 2017.The research work was carried out after obtaining ethical clearance from concerned departments, Research Review Committee and Ethical Review Committee of Dhaka medical college, Dhaka. The patients were selected from outpatient department of Endocrinology, Dhaka medical college and personal contact from Dhaka city. At the Beginning of study 60 diagnosed type-2 diabetic patients were randomly selected on the basis of exclusion and inclusion criteria. There were 30 patients of control group and 30 patients of study groups recruited for completion of study, After 6 weeks of study period,3 patients were dropped out from study group and 5 patients were dropped out from control group. Finally, total 52 type diabetic patient of both sexes with the age ranging from 40-50 years with FBG 7.0 mmol/l or 126 mg/dl, HbA1c 6.5%, serum TC 200 mg/dl, serum TG 150 mg/dl,BMI £30 Kg/m 2 were included in this study. Subjects with history of heart, liver, endocrine disorder, insulin therapy and pregnant women were excluded from this study. For this study, 27 diagnosed type-2 diabetic patients with omega-3 fatty acid supplementation were selected as study group and 25 type-2 diabetic patients without oral omega-3 fatty supplementation were selected as control group. The study group again sub-divided into presupplementation group and after 12 weeks of supplementation as post supplementation group. The control group was sub-divided as pre and post follow-up group. After selection, the nature, purpose and benefits of the study were explained to each subject and informed written consent was taken from participants. Before taking blood detailed family and medical history were taken. Anthropometric measurement of the subjects was recorded and blood pressure was measured. All the information were recorded in a data schedule. With aseptic precaution, 5 ml of venous blood was collected from ante-cubital vein by a disposable plastic syringe from each subject after overnight fasting for biochemical tests. Serum TC and TG were estimated in enzymatic end point method by auto analyzer in department of Laboratory Medicine Dhaka Medical College Hospital, Dhaka.Omega-3 fatty acid (2gm) was supplied to study group then they were asked to intake twice daily for 12 weeks with proper instructions. Subjects were instructed not to change their diet and physical activities during the course of the study. A regular telephonic contact and periodic visit was made to participants because most of them are employee of Dhaka medical college. For statistical analysis, Paired Student's 't' test and Unpaired Student's 't' test were performed as applicable using SPSS for windows version 16.0.Datawere expressed as mean±SE.The p value of < 0.05 was accepted as level of significance.
Results
In this study no significant difference were observed in age, sex, BMI, systolic and diastolic blood pressure between study and control group (Table 1) .In this study, the mean serum TC and TG levels were almost similar and there is no statistical difference were observed at the beginning of the study. In study group, the mean serum TC (p<.0.001) and TG (p<.0.001) levels were found significantly lower in post supplementation group, than pre-supplementation group. Again the mean serum TC (p<.0.001) and TG (p<0.015) levels were found significantly lower in study group compared to control group. In control group, there was no significant difference in mean serum TC and TG between pre and post follow-up group. Results were expressed as mean ± SD. a=Unpaired Student's't' test was performed to compare between the groups. b= Chi Square test was performed to compare male and female between the groups. The test of significance was calculated and p value < 0.05 was accepted as level of significance. N= total number of subjects, n = number of subjects in each group T2DMS=Type 2 DM with supplementation T2DM=Type 2 DM without supplementation
Discussion
In the present study, the mean serum TC, mean TG were significantly lower in patients of T2DM after supplementation with omega-3 fatty acid in comparison to that of their baseline value. Again, after 12 weeks, mean TG levels were significantly lower in type-2 diabetic patients supplemented with omega-3 fatty acid in comparison to that of diabetic control group without omega-3 fatty acid. Almost similar results were observed by different researchers of different countries [13] [14] [15] [16] . On the contrary, there were no significant difference in lipid profile in patients after supplementation of omega-3 fatty acid in comparison to that of their baseline values and diabetic control group who were not supplemented with omega-3 fatty acid 17 . There were a history of less physical activity in the study subjects that might be contributed the result of those study. Literature review suggested that, when serum TG level rises, it decreases the binding of insulin with its receptor through releasing some inflammatory mediator from liver that decreases insulin receptor signaling activity.Omega-3fatty acid has a role on reducing serum TG level. Peroxisome proliferator receptor-á exists in the liver which increase in number in presence of omega-3 fatty acid.Anincrease in PPAR-á leads to hepatic uptake of free fatty acid. It also increases the free consequence of free fatty acid reduction helps to decrease TG synthesis. Thus, omega-3 fatty acid reduces serum TG level that facilitates the binding of insulin to its receptor and improves insulin sensitivity 18 .Omega-3 fatty acid supplementation decreases serum cholesterol level by decreasing glycolytic and lipogenic enzymes which are necessary for cholesterol synthesis. The transcription factor Sterol Regulatory Element Binding Protein-1(SREBP-1)is a precursor of cholesterol synthesis, which play an important role in expression of lipogenic genes.Omega-3 fatty acid inhibit lipogenic genes by suppressing the SREBP-1 as a result decreases cholesterol synthesis, when serum cholesterol level decreases insulin can easily bind with its receptor and improves insulin sensitivity 19 .
In the present study serum-TG and TC levels decreases in patients with T2DMafter supplementation of omega-3 fatty acid in comparison to their baseline value and control group. Omega-3 fatty acid supplementation increases free fatty acid oxidation as a result serum TG level decreases and it also decreases cholesterol synthesis by suppressing SREBP-1. This facilitates the binding of insulin to its receptor and improves insulin sensitivity.
Conclusions
After analyzing the results of the study, it can be concluded that supplementation of omega-3 fatty acid can improve serum TC and serum TG levels in patients with type-2 DM. Therefore, omega-3 fatty acid containing food may be helpful to minimize the complications in type-2 DM.
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